Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous limbal progenitor cell therapy on amniotic membrane for unilateral severe limbal stem cell deficiency
2009-016490-16Phase 2Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Mar 2010
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous limbal progenitor cells in limbal stem cell deficiency (LSCD), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoints: Clinical data, Ophthalmologic medical history and 8 more. Started Mar 2010; status: active.
02
Drugs
autologous limbal progenitor cells
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on 2009-016490-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016490-16.